International Edition
Latest News
Health

Pedro Martín outlines sheep pneumonia pathogens at Foro Ovino

Pasteurella Multocida Rises as Mannheimia Haemolytica Dominates Sheep Pneumonia Cases Pneumonic pasteurellosis remains one of the most economically damaging respiratory diseases in sheep, yet the condition involves a complex interplay of bacteria, viruses, environmental conditions, management practices, and…

Pedro Martín outlines sheep pneumonia pathogens at Foro Ovino

Pasteurella Multocida Rises as Mannheimia Haemolytica Dominates Sheep Pneumonia Cases

Pneumonic pasteurellosis remains one of the most economically damaging respiratory diseases in sheep, yet the condition involves a complex interplay of bacteria, viruses, environmental conditions, management practices, and animal stress rather than a simple bacterial infection, according to Interempresas Media. Veterinary specialist Pedro Martín outlined these findings at the Foro Ovino 2026 conference on October 19, 2026, noting that while traditional views treated the disease as a straightforward bacterial invasion, the pathogens involved frequently reside within the normal respiratory microbiota of healthy animals.

Mannheimia haemolytica, particularly serotype A2, remains the most frequently isolated agent in sheep respiratory disease. However, recent data presented at the event show a growing presence of Pasteurella multocida type A, which now accounts for approximately 40% of studied cases. This shift challenges the long-held assumption that P. multocida plays only a secondary role in ovine respiratory infections.

Subclinical Losses Outweigh Mortality Rates in Affected Flocks

The economic toll of ovine pasteurellosis extends far beyond acute mortality and immediate treatment costs. Chronic and subclinical pneumonia inflict hidden productivity losses that degrade flock profitability over the long term. Studies cited at the forum indicate that subclinical cases can reduce average daily weight gain by up to 35 grams per animal, worsen feed conversion ratios by roughly 25%, delay overall growth, and increase slaughterhouse carcass condemnations.

While severe cases result in sudden death or visible respiratory distress, a large proportion of animals survive with permanent pulmonary damage, including lung consolidations and fibrinous pleuritis. These survivors never reach their full productive potential, making the disease a persistent threat to farm economics amid shrinking flock inventories and rising production costs.

Bacterial Diversity Complicates Diagnosis and Vaccine Efficacy

Diagnostic complexity stems from the vast genetic and capsular variability within the disease-causing agents. In Mannheimia haemolytica, serotypes A7, A8, A9, and A13 are gaining clinical importance alongside the classical A1, A2, and A6 serotypes. Similarly, Pasteurella multocida exhibits substantial genetic diversity, while Bibersteinia trehalosi frequently drives hyperacute outbreaks and sudden post-weaning mortality.

This biological diversity hinders epidemiological tracking and complicates the development of universal vaccines capable of protecting against all circulating variants. Consequently, relying solely on nasal swabs yields limited diagnostic value because the bacteria naturally inhabit the upper respiratory tract. Accurate diagnosis requires lung tissue samples or bronchoalveolar lavages analyzed via bacterial isolation, MALDI-TOF mass spectrometry, PCR, or serological testing.

Antimicrobial Resistance Forces a Shift Toward Comprehensive Prevention

Antimicrobial treatment faces mounting limitations due to high resistance levels against sulfonamides, aminoglycosides, and lincosamides, alongside rising resistance to macrolides. Data discussed at Foro Ovino 2026 reveal that more than 32% of isolates display multi-drug resistance, with roughly 2.4% resisting five distinct antibiotic families. This high resistance profile demands routine microbiological testing and antibiograms rather than indiscriminate antibiotic use.

Experts emphasize that vaccination serves as an essential production investment to reduce mortality, improve growth rates, and lower antibiotic dependency, but it cannot succeed in isolation. Effective disease control requires producers to move away from reactive treatments and implement comprehensive health management programs that simultaneously address environmental stressors, ventilation, and biosecurity.

Frequently Asked Questions About Ovine Pasteurellosis Control

Which bacterial serotype is most commonly isolated in sheep pneumonia cases?

Mannheimia haemolytica, particularly serotype A2, remains the most frequently isolated agent in ovine respiratory disease, though Pasteurella multocida type A now appears in approximately 40% of cases.

What specific productivity losses are caused by subclinical pneumonia?

Subclinical infections reduce average daily weight gain by up to 35 grams per animal, impair feed conversion efficiency by about 25%, delay growth, and lead to higher rates of slaughterhouse carcass condemnations.

Why are nasal swabs considered unreliable for diagnosing pasteurellosis?

Because the bacteria responsible for the disease frequently form part of the normal upper respiratory microbiota in healthy sheep, nasal swab isolates have very limited diagnostic value compared to lung samples or bronchoalveolar lavages.

What level of multi-drug resistance has been detected in recent bacterial isolates?

Recent studies show that more than 32% of bacterial isolates exhibit resistance to multiple antimicrobial families simultaneously, with approximately 2.4% demonstrating resistance to five different antibiotic families.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”